A Nutrient Formulation Affects Developmental Myelination in Term Infants: A Randomized Clinical Trial

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Nutritional Science

Background:

• Observational studies indicate potential differences in myelination between breast-fed and formula-fed infants.
• Myelination is a critical brain development process influencing learning and cognitive abilities.

Purpose of the Study:

• To evaluate the efficacy of a novel infant formula blend on myelination, cognitive, and behavioral development.
• The blend contains docosahexaenoic acid (DHA), arachidonic acid (ARA), iron, vitamin B12, folic acid, and sphingomyelin (SM).

Main Methods:

• A 6-month, randomized controlled trial involving 81 full-term, neurotypical infants.
• Infants were randomized to an investigational formula or a control formula.
• Magnetic Resonance Imaging (MRI) and standardized developmental assessments were used to measure outcomes.

Main Results:

• Significant improvements in myelin structure, volume, and myelination rate were observed in the investigational group at 3 and 6 months.
• Positive effects were noted in whole brain myelin and specific regions (cerebellar, parietal, occipital, temporal).
• No significant differences were found in early cognitive or behavioral scores.

Conclusions:

• This study provides the first evidence for the efficacy of a specific myelin nutrient blend in term infants.
• The blend positively impacts developmental myelination, potentially supporting future cognitive and learning outcomes.